XML 15 R4.htm IDEA: XBRL DOCUMENT v3.25.1
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Income Statement [Abstract]    
Net Sales $ 18,914 $ 22,676
Cost of Sales 15,872 19,612
Gross Profit 3,042 3,064
Research and Product Development 0 18
Selling and Marketing 711 594
General and Administrative 3,691 3,776
Operating Loss (1,360) (1,324)
Other Income (Expense):    
Realized Gain on Available-for-Sale Investments 56 0
Interest Expense (277) (431)
Interest Income 66 24
Total Other Expense, net (155) (407)
Net Loss $ (1,515) $ (1,731)
Basic Net Loss per Share (in dollars per share) $ (0.04) $ (0.06)
Diluted Net Loss per Share (in dollars per share) $ (0.04) $ (0.06)
Basic Weighted Average Shares Outstanding (in shares) 34,107,640 29,327,204
Diluted Weighted Average Shares Outstanding (in shares) 34,107,640 29,327,204